Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
sertindole alpha-1a adrenergic receptor small molecule NA drugbank , DGIDB Schizophrenia[MeSHID:D012559]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.12 approved,investigational,withdrawn unknown
sertindole alpha-1b adrenergic receptor small molecule NA drugbank , DGIDB Schizophrenia[MeSHID:D012559]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.13 approved,investigational,withdrawn unknown
sertindole alpha-1d adrenergic receptor small molecule NA drugbank , DGIDB Schizophrenia[MeSHID:D012559]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.21 approved,investigational,withdrawn unknown
sertindole dopamine d2 receptor small molecule Successful target TTD , drugbank , DGIDB Schizophrenia[MeSHID:D012559]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.15 approved,investigational,withdrawn,withdrawn from market antagonist
sertindole 5-hydroxytryptamine receptor 2a small molecule NA drugbank , DGIDB Schizophrenia[MeSHID:D012559]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.14 approved,investigational,withdrawn antagonist
sertindole 5-hydroxytryptamine receptor 2c small molecule NA drugbank , DGIDB Schizophrenia[MeSHID:D012559]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.17 approved,investigational,withdrawn antagonist
sertindole 5-hydroxytryptamine receptor 6 small molecule NA drugbank , DGIDB Schizophrenia[MeSHID:D012559]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.31 approved,investigational,withdrawn antagonist
sertindole potassium voltage-gated channel subfamily h member 2 small molecule NA drugbank , DGIDB Schizophrenia[MeSHID:D012559]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.08 approved,investigational,withdrawn inhibitor
click here to return to the previous page